Sarepta Therapeutics (SRPT) Amortization - Intangibles (2017 - 2026)

Sarepta Therapeutics' Amortization - Intangibles history runs 10 years deep, the most recent figure standing at $691000.0 for Q1 2026.

• On a quarterly basis, Amortization - Intangibles rose 14.98% year-over-year to $691000.0 in Q1 2026; TTM through Mar 2026 was $2.7 million, a 12.77% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 9.02% from the prior year.
• Amortization - Intangibles advanced to $691000.0 in Q1 2026 per SRPT's latest filing, from $677000.0 in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $763000.0 in Q4 2023 and bottomed at $178000.0 in Q1 2022.
• The 5-year median for Amortization - Intangibles is $601000.0 (2024), against an average of $470058.8.
• Across the five-year window, Amortization - Intangibles surged 326.26% in 2023 and decreased 21.23% in 2024, its largest moves.
• Year by year, Amortization - Intangibles stood at $179000.0 in 2022, then surged by 326.26% to $763000.0 in 2023, then dropped by 21.23% to $601000.0 in 2024, then gained by 12.65% to $677000.0 in 2025, then rose by 2.07% to $691000.0 in 2026.
• Per Business Quant, the three latest SRPT Amortization - Intangibles figures stand at $691000.0 (Q1 2026), $677000.0 (Q4 2025), and $677000.0 (Q3 2025).